|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.20 BRL | +27.02% |
|
-1.45% | +36.91% |
| Mar. 30 | Natura Cosméticos S.A. Announces Board and Committee Changes | CI |
| Mar. 30 | Brazil's Natura announces stake purchase by Advent as founders exit board | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.67 | 0.5 | 1.82 | 2.9 | 4.52 | |||||
Return on Total Capital | 2.25 | 0.68 | 2.55 | 4.29 | 6.95 | |||||
Return On Equity % | 4.07 | -9.73 | -11.36 | -3.83 | 4.77 | |||||
Return on Common Equity | 4.1 | -9.75 | -11.37 | -3.83 | 4.77 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 65.11 | 63.81 | 63.81 | 65.24 | 66.61 | |||||
SG&A Margin | 59.67 | 60.81 | 57 | 55.38 | 53.65 | |||||
EBITDA Margin % | 6.77 | 3.95 | 5.96 | 9.56 | 9.66 | |||||
EBITA Margin % | 4.92 | 2.1 | 6.42 | 8.25 | 8.51 | |||||
EBIT Margin % | 4.03 | 1.27 | 5.31 | 7.68 | 8.16 | |||||
Income From Continuing Operations Margin % | 2.84 | -6.82 | -9.66 | -3.08 | 2.42 | |||||
Net Income Margin % | 2.61 | -7.87 | 11.12 | -37.07 | -8.18 | |||||
Net Avail. For Common Margin % | 2.85 | -6.82 | -9.66 | -3.08 | 2.42 | |||||
Normalized Net Income Margin | 1.04 | -2.02 | -2.12 | 3.83 | 2.67 | |||||
Levered Free Cash Flow Margin | 3.71 | 8.8 | -0.58 | -7.35 | 9.37 | |||||
Unlevered Free Cash Flow Margin | 5.03 | 10.42 | 5.09 | -5.82 | 11.03 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.66 | 0.63 | 0.55 | 0.6 | 0.89 | |||||
Fixed Assets Turnover | 4.69 | 4.44 | 4.31 | 5.33 | 7.36 | |||||
Receivables Turnover (Average Receivables) | 11.36 | 10.42 | 7.61 | 5.47 | 3.9 | |||||
Inventory Turnover (Average Inventory) | 2.82 | 2.65 | 2.54 | 2.59 | 2.72 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.27 | 1.21 | 1.54 | 1.58 | 1.65 | |||||
Quick Ratio | 0.8 | 0.8 | 1.16 | 1.19 | 1.2 | |||||
Operating Cash Flow to Current Liabilities | -0.01 | 0.05 | -0.23 | -0.27 | -0.02 | |||||
Days Sales Outstanding (Average Receivables) | 32.14 | 35.04 | 47.96 | 66.89 | 93.7 | |||||
Days Outstanding Inventory (Average Inventory) | 129.57 | 137.63 | 143.43 | 141.32 | 134.04 | |||||
Average Days Payable Outstanding | 157.45 | 176.64 | 225.07 | 245.97 | 221.93 | |||||
Cash Conversion Cycle (Average Days) | 4.27 | -3.98 | -33.68 | -37.76 | 5.81 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 56.94 | 75.45 | 31.41 | 49.9 | 52.16 | |||||
Total Debt / Total Capital | 36.28 | 43 | 23.9 | 33.29 | 34.28 | |||||
LT Debt/Equity | 50.11 | 70.03 | 29.41 | 48.22 | 49.91 | |||||
Long-Term Debt / Total Capital | 31.93 | 39.92 | 22.38 | 32.17 | 32.8 | |||||
Total Liabilities / Total Assets | 52.74 | 59.13 | 45.91 | 57.8 | 55.21 | |||||
EBIT / Interest Expense | 1.92 | 0.49 | 0.58 | 3.14 | 3.08 | |||||
EBITDA / Interest Expense | 4.4 | 2.5 | 0.94 | 4.3 | 4.06 | |||||
(EBITDA - Capex) / Interest Expense | 2.65 | 1.33 | 0.55 | 3.37 | 3.4 | |||||
Total Debt / EBITDA | 4.37 | 7.14 | 3.17 | 3.09 | 2.89 | |||||
Net Debt / EBITDA | 2.76 | 4.6 | -0.21 | 1.33 | 1.75 | |||||
Total Debt / (EBITDA - Capex) | 7.26 | 13.39 | 5.41 | 3.94 | 3.44 | |||||
Net Debt / (EBITDA - Capex) | 4.59 | 8.63 | -0.36 | 1.7 | 2.08 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.78 | -9.5 | -8.51 | 21.48 | 2.59 | |||||
Gross Profit, 1 Yr. Growth % | 9.91 | -11.02 | -2.24 | 23.68 | 2.31 | |||||
EBITDA, 1 Yr. Growth % | 3.37 | -49.83 | 49.68 | 31.61 | -7.9 | |||||
EBITA, 1 Yr. Growth % | 2.93 | -63.84 | 334.69 | 6.02 | -10.15 | |||||
EBIT, 1 Yr. Growth % | 1.51 | -73.86 | 1.47K | 17.45 | -13.78 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -318.85 | -317.53 | 14.2 | 223.8 | -48.61 | |||||
Net Income, 1 Yr. Growth % | -261.18 | -372.88 | -203.99 | -400.21 | -334.7 | |||||
Normalized Net Income, 1 Yr. Growth % | 4.87 | -245.16 | -36.66 | 1.03K | -52.15 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -301.63 | -320.14 | 13.69 | 222.71 | -76.61 | |||||
Accounts Receivable, 1 Yr. Growth % | -3.37 | 0.75 | 0.63 | 49.83 | -28.27 | |||||
Inventory, 1 Yr. Growth % | 18.91 | -16.41 | -31.65 | 9.42 | 24.26 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.9 | -6.67 | -42.99 | 0.63 | 12.08 | |||||
Total Assets, 1 Yr. Growth % | -0.77 | -9.53 | -21.83 | -13.13 | 42.61 | |||||
Tangible Book Value, 1 Yr. Growth % | 277.46 | -154.99 | -803.85 | -51.14 | -69.32 | |||||
Common Equity, 1 Yr. Growth % | 4.32 | -21.76 | 3.45 | -32.17 | 40.9 | |||||
Cash From Operations, 1 Yr. Growth % | -108.88 | -688.19 | -449.6 | 17.39 | -106.02 | |||||
Capital Expenditures, 1 Yr. Growth % | 119.4 | -25.45 | 23.66 | -14.26 | -19.74 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -60.95 | 106.71 | -107.69 | -421.22 | -156.71 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -54.16 | 82.56 | -53.01 | -230.9 | -171.5 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 66.75 | -0.78 | -18.41 | -9.21 | 4.9 | |||||
Gross Profit, 2 Yr. CAGR % | 58.49 | -1.27 | -19.1 | -5.1 | 6.95 | |||||
EBITDA, 2 Yr. CAGR % | 25.64 | -26.17 | -25.33 | 37.84 | 9.73 | |||||
EBITA, 2 Yr. CAGR % | 18.77 | -36.88 | -9.88 | 127.54 | -0.42 | |||||
EBIT, 2 Yr. CAGR % | 9.54 | -46.32 | -10.21 | 119.63 | 6.32 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 170.7 | 118.19 | 50.54 | -42.71 | 51.92 | |||||
Net Income, 2 Yr. CAGR % | 159.63 | 109.72 | 68.45 | 76.71 | -22.53 | |||||
Normalized Net Income, 2 Yr. CAGR % | 1.12 | 35.62 | 5.84 | -17.49 | 167.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 114.81 | 110.68 | 51.11 | -42.94 | 25.41 | |||||
Accounts Receivable, 2 Yr. CAGR % | 43.6 | -1.33 | 0.69 | 22.79 | 15.23 | |||||
Inventory, 2 Yr. CAGR % | 94.35 | -0.3 | -24.41 | -13.52 | -1.99 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 38.87 | -4.31 | -27.06 | -24.26 | -16.6 | |||||
Total Assets, 2 Yr. CAGR % | 68.92 | -5.25 | -15.91 | -17.6 | -17.68 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.77 | 44.07 | 96.74 | 85.45 | -37.09 | |||||
Common Equity, 2 Yr. CAGR % | 191.37 | -9.66 | -10.04 | -16.23 | -25.05 | |||||
Cash From Operations, 2 Yr. CAGR % | -70.37 | -27.73 | 353.46 | 94.99 | -77.01 | |||||
Capital Expenditures, 2 Yr. CAGR % | 58.83 | 27.9 | -19.98 | -15.44 | -22.92 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 0.77 | -8.48 | -68.23 | 9.1 | 92.61 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 4 | -7.26 | -18.98 | -26.59 | 49.83 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.44 | - | 131.99 | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 44.19 | 36.02 | -10.2 | -15.67 | -9.27 | |||||
Gross Profit, 3 Yr. CAGR % | 39.59 | 30.61 | -10.5 | -15.52 | -5.91 | |||||
EBITDA, 3 Yr. CAGR % | 14.47 | -5.93 | -15.39 | -6.94 | 20.24 | |||||
EBITA, 3 Yr. CAGR % | 10.92 | -18.27 | -3.63 | -2.05 | 69.19 | |||||
EBIT, 3 Yr. CAGR % | 5.49 | -30.16 | -3.85 | 1.69 | 66.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 27.6 | 151.67 | 70.54 | -13.31 | -38.38 | |||||
Net Income, 3 Yr. CAGR % | 24.1 | 163.97 | 65.99 | 104.25 | -14.53 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.65 | 21.5 | 12.38 | 22.27 | -24.55 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 9.08 | 116.57 | 66.36 | -13.2 | -45.86 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.14 | 27.6 | -0.68 | 14.95 | 10.14 | |||||
Inventory, 3 Yr. CAGR % | 58.2 | 46.7 | -12.09 | -14.49 | -13.09 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 55.89 | 21.64 | -19.48 | -18.8 | -26.53 | |||||
Total Assets, 3 Yr. CAGR % | 57.81 | 37.18 | -11.14 | -14.99 | -19.08 | |||||
Tangible Book Value, 3 Yr. CAGR % | -10.78 | -18.49 | 144.46 | 23.67 | 40.71 | |||||
Common Equity, 3 Yr. CAGR % | 123 | 87.97 | -5.49 | -18.12 | -16.55 | |||||
Cash From Operations, 3 Yr. CAGR % | -48.67 | -19.77 | 22.23 | 181.74 | -44.47 | |||||
Capital Expenditures, 3 Yr. CAGR % | 45.02 | 23.43 | 12 | -28.2 | -20.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 39.75 | 29.63 | -65.55 | 4.61 | 11.19 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 28.98 | 26.61 | -32.38 | -12.23 | -2.59 | |||||
Dividend Per Share, 3 Yr. CAGR % | -9.21 | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 38.39 | 29.83 | 14.82 | 10.77 | -9.98 | |||||
Gross Profit, 5 Yr. CAGR % | 36.72 | 27.29 | 12.16 | 8.59 | -9.39 | |||||
EBITDA, 5 Yr. CAGR % | 16.33 | -4.17 | -2.55 | 5.98 | -4.34 | |||||
EBITA, 5 Yr. CAGR % | 12.57 | -11.29 | 3.48 | 7.25 | -0.64 | |||||
EBIT, 5 Yr. CAGR % | 8.29 | -19.86 | 0.55 | 6.5 | 2.21 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 29.88 | 29.89 | 36.32 | 36.7 | 0.32 | |||||
Net Income, 5 Yr. CAGR % | 28.71 | 33.66 | 40.23 | 124.82 | 22.39 | |||||
Normalized Net Income, 5 Yr. CAGR % | 10.09 | 1.95 | 1.94 | 17.7 | 7.88 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 19.01 | 18.51 | 24.27 | 24.72 | -8.46 | |||||
Accounts Receivable, 5 Yr. CAGR % | 27.01 | 18.36 | 15.81 | 25.66 | 5.4 | |||||
Inventory, 5 Yr. CAGR % | 45.25 | 29.42 | 17.74 | 18.75 | -8.18 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 37.33 | 28.28 | 15.05 | 0.64 | -18.34 | |||||
Total Assets, 5 Yr. CAGR % | 48.32 | 29.6 | 22.69 | 11.88 | -13.81 | |||||
Tangible Book Value, 5 Yr. CAGR % | 51.41 | -20.05 | 22.42 | 13.24 | 42.04 | |||||
Common Equity, 5 Yr. CAGR % | 95.62 | 68.69 | 55.1 | 36.05 | -13.86 | |||||
Cash From Operations, 5 Yr. CAGR % | -27.24 | -7.48 | 22.7 | 14.45 | -38.3 | |||||
Capital Expenditures, 5 Yr. CAGR % | 48.02 | 24.79 | 14.32 | -1.36 | -10.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 4.79 | 71.83 | -22.15 | 3.83 | -11.73 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 7.92 | 52.73 | 7.68 | -5.55 | -11.39 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0.83 | - | 32.13 | - | - |
- Stock Market
- Equities
- NATU3 Stock
- Financials Natura Cosméticos S.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















